Sectors & IndustriesHealthcareMedical Devices

Best Medical Device Stocks to Buy Now (2026)

Top medical device stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical device stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical equipment stocks to buy right now are:

Bioventus (NASDAQ:BVS) is the #1 top medical device stock out of 139 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 32, which is 5 points higher than the medical device industry average of 27.

BVS passed 11 out of 33 due diligence checks and has average fundamentals. Bioventus has seen its stock lose -9.76% over the past year, overperforming other medical device stocks by 57 percentage points.

Bioventus has an average 1 year price target of $13.00, an upside of 48.06% from Bioventus's current stock price of $8.78.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Electromed (NYSEMKT:ELMD) is the #2 top medical device stock out of 139 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: B, Growth: C, Momentum: C, Sentiment: A, Safety: A, Financials: A, and AI: B.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 54, which is 27 points higher than the medical device industry average of 27.

ELMD passed 18 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock lose -11.67% over the past year, overperforming other medical device stocks by 55 percentage points.

Electromed has an average 1 year price target of $36.00, an upside of 51.9% from Electromed's current stock price of $23.70.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Livanova (NASDAQ:LIVN) is the #3 top medical device stock out of 139 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Livanova (NASDAQ:LIVN) is: Value: C, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: A.

Livanova (NASDAQ:LIVN) has a Due Diligence Score of 20, which is -7 points lower than the medical device industry average of 27. Although this number is below the industry average, our proven quant model rates LIVN as a "A".

LIVN passed 6 out of 33 due diligence checks and has weak fundamentals. Livanova has seen its stock return 72.49% over the past year, overperforming other medical device stocks by 139 percentage points.

Livanova has an average 1 year price target of $74.50, an upside of 5.52% from Livanova's current stock price of $70.60.

Livanova stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Livanova, 33.33% have issued a Strong Buy rating, 50% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 7 medical device stocks that have issued dividends in the past year, the 3 medical device stocks with the highest dividend yields are:

Smith & Nephew (NYSE:SNN) has an annual dividend yield of 2.07%, which is 1 percentage points higher than the medical device industry average of 1.13%. Smith & Nephew's dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Smith & Nephew's dividend has not shown consistent growth over the last 10 years.

Smith & Nephew's dividend payout ratio of 66.7% indicates that its dividend yield is sustainable for the long-term.

Abbott Laboratories (NYSE:ABT) has an annual dividend yield of 2.06%, which is 1 percentage points higher than the medical device industry average of 1.13%. Abbott Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Abbott Laboratories's dividend has shown consistent growth over the last 10 years.

Abbott Laboratories's dividend payout ratio of 64.3% indicates that its dividend yield is sustainable for the long-term.

Iradimed (NASDAQ:IRMD) has an annual dividend yield of 1.17%, which is the same as the medical device industry average of 1.13%. Iradimed's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. Iradimed's dividend has not shown consistent growth over the last 10 years.

Iradimed's dividend payout ratio of 39.5% indicates that its dividend yield is sustainable for the long-term.

Medical device stocks were down -0.3% in the last day, and up 0.42% over the last week.

We couldn't find a catalyst for why medical device stocks are down.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical device stocks right now are:

Inmode (NASDAQ:INMD) is the most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 100, which is 85 points higher than the medical device industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -25.96% in the past year. It has overperformed other stocks in the medical device industry by 41 percentage points.

Conmed (NYSE:CNMD) is the second most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Conmed has a valuation score of 57, which is 42 points higher than the medical device industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Conmed's stock has dropped -22.6% in the past year. It has overperformed other stocks in the medical device industry by 44 percentage points.

Bioventus (NASDAQ:BVS) is the third most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bioventus has a valuation score of 14, which is -1 points higher than the medical device industry average of 15. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates BVS a Valuation Rating of "A".

Bioventus's stock has dropped -9.76% in the past year. It has overperformed other stocks in the medical device industry by 57 percentage points.

55.56% of medical device stocks rated by analysts are a strong buy right now. On average, analysts expect medical device stocks to rise by 39.09% over the next year.

6.86% of medical device stocks have a Zen Rating of A (Strong Buy), 16.67% of medical device stocks are rated B (Buy), 51.96% are rated C (Hold), 17.65% are rated D (Sell), and 6.86% are rated F (Strong Sell).